Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
Research Square
|
July 3, 2023
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy in vivo
Vignesh Narayan Hariharan, Jillian Caiazzi, Rachael Miller, et al.
Brain : a Journal of Neurology
|
January 25, 2014
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation
Ulrike Träger, Ralph Andre, Nayana Lahiri, et al.
Nucleic Acids Research
|
February 13, 2018
Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo
Matthew R Hassler, Anton A Turanov, Julia F Alterman, et al.
Human Gene Therapy
|
December 7, 2017
Artificial miRNAs Reduce Human Mutant Huntingtin Throughout the Striatum in a Transgenic Sheep Model of Huntington's Disease
Edith L Pfister, Natalie DiNardo, Erica Mondo, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy
Ken Yamada, Vignesh Narayan Hariharan, Jillian Caiazzi, et al.
Science Translational Medicine
|
March 18, 2026
Lowering the <i>HTT1a</i> transcript as an effective therapy for Huntington's disease in a knockin mouse model
Aikaterini Smaragdi Papadopoulou, Julia Alterman, Christian Landles, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Blocking somatic repeat expansion and lowering huntingtin via RNA interference synergize to prevent Huntington's disease pathogenesis in mice
Jillian Belgrad, Ashley Summers, Christian Landles, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2026
Mismatch repair dissection by in vivo RNAi reveals dose-dependent modulators of somatic instability and proteome remodeling in Huntington's disease
Jillian Belgrad, Todd M Greco, Ellen Sapp, et al.
Iscience
|
June 14, 2019
Serum Deprivation of Mesenchymal Stem Cells Improves Exosome Activity and Alters Lipid and Protein Composition
Reka Agnes Haraszti, Rachael Miller, Michelle L Dubuke, et al.
Nature Biotechnology
|
August 1, 2024
Enhancing siRNA efficacy in vivo with extended nucleic acid backbones
Ken Yamada, Vignesh N Hariharan, Jillian Caiazzi, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
Research Square
|
July 3, 2023
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy in vivo
Vignesh Narayan Hariharan, Jillian Caiazzi, Rachael Miller, et al.
Brain : a Journal of Neurology
|
January 25, 2014
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation
Ulrike Träger, Ralph Andre, Nayana Lahiri, et al.
Nucleic Acids Research
|
February 13, 2018
Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo
Matthew R Hassler, Anton A Turanov, Julia F Alterman, et al.
Human Gene Therapy
|
December 7, 2017
Artificial miRNAs Reduce Human Mutant Huntingtin Throughout the Striatum in a Transgenic Sheep Model of Huntington's Disease
Edith L Pfister, Natalie DiNardo, Erica Mondo, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy
Ken Yamada, Vignesh Narayan Hariharan, Jillian Caiazzi, et al.
Science Translational Medicine
|
March 18, 2026
Lowering the <i>HTT1a</i> transcript as an effective therapy for Huntington's disease in a knockin mouse model
Aikaterini Smaragdi Papadopoulou, Julia Alterman, Christian Landles, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Blocking somatic repeat expansion and lowering huntingtin via RNA interference synergize to prevent Huntington's disease pathogenesis in mice
Jillian Belgrad, Ashley Summers, Christian Landles, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2026
Mismatch repair dissection by in vivo RNAi reveals dose-dependent modulators of somatic instability and proteome remodeling in Huntington's disease
Jillian Belgrad, Todd M Greco, Ellen Sapp, et al.
Iscience
|
June 14, 2019
Serum Deprivation of Mesenchymal Stem Cells Improves Exosome Activity and Alters Lipid and Protein Composition
Reka Agnes Haraszti, Rachael Miller, Michelle L Dubuke, et al.
Nature Biotechnology
|
August 1, 2024
Enhancing siRNA efficacy in vivo with extended nucleic acid backbones
Ken Yamada, Vignesh N Hariharan, Jillian Caiazzi, et al.
Page
of 11